Whether increased adipose tissue fibrosis in young patients with SRC-1 variants predisposes them to the early development of metabolic complications such as type 2 diabetes and fatty liver disease is an important question that needs to be addressed in larger longitudinal studies. This evidence concerns the gene NCOA1 and fatty liver disease.